Erratum: Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators(Journal of Medicinal Chemistry (2014) 57 (2334-2356) DOI: 10.1021/jm401695d);Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators

Journal of Medicinal Chemistry

Volumn 57, Issue 6, 2014, Pages 2334-2356

  Zimmerman, Sommer S ^a   Khatri, Alpa ^b   Garnier Amblard, Ethel C ^a,b   Mullasseril, Praseeda ^b   Kurtkaya, Natalie L ^b   Gyoneva, Stefka ^b   Hansen, Kasper B ^b   Traynelis, Stephen F ^b   Liotta, Dennis C ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLIC AMP RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PYRROLIDINE DERIVATIVE; RECOMBINANT RECEPTOR;

ALLOSTERISM; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTATIONAL BIOLOGY; DRUG DESIGN; EXCITATORY AMINO ACID AGONISTS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OOCYTES; PATCH-CLAMP TECHNIQUES; PYRROLIDINONES; PYRUVATES; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; XENOPUS LAEVIS;

EID: 84897425744     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.5b00199     Document Type: Erratum

References (33)

1. Furukawa, H.; Gouaux, E. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core EMBO J. 2003, 22, 2873-2885
2. Furukawa, H.; Singh, S. K.; Mancusso, R.; Gouaux, E. Subunit arrangement and function in NMDA receptors Nature 2005, 438 (7065) 185-192
3. Traynelis, S.; Wollmuth, L.; McBain, C.; Menniti, F.; Vance, K.; Ogden, K.; Hansen, K.; Yuan, H.; Myers, S.; Dingledine, R. Glutamate Receptor Ion Channels: Structure, Regulation and Function Pharmacol. Rev. 2010, 62, 405-496
4. Akazawa, C.; Shigemoto, R.; Bessho, Y.; Nakanishi, S.; Mizuno, N. Differential expression of five N -methyl- d -aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats J. Comp. Neurol. 1994, 347, 150-160
5. Monyer, H.; Burnashev, N.; Laurie, D. J.; Sakmann, B.; Seeburg, P. H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 1994, 12, 529-540
6. Vicini, S.; Wang, J. F.; Li, J. H.; Zhu, W. J.; Wang, Y. H.; Luo, J. H.; Wolfe, B. B.; Grayson, D. R. Functional and pharmacological differences between recombinant N -methyl- d -aspartate receptors J Neurophysiol. 1998, 72, 555-566
7. Yuan, H.; Hansen, K. B.; Vance, K. M.; Ogden, K. K.; Traynelis, S. F. Control of NMDA receptor function by the NR2 subunit amino-terminal domain J. Neurosci. 2009, 29, 12045-12058
8. Paoletti, P.; Neyton, J. NMDA receptor subunits: function and pharmacology Curr. Opin. Pharmacol. 2007, 7, 39-47
9. Nakanishi, S. Molecular diversity of glutamate receptors and implications for brain function Science 1992, 258, 597-603
10. Nicoll, R. A.; Malenka, R. C. Expression mechanisms underlying NMDA receptor-dependent long-term potentiation Ann. N. Y. Acad. Sci. 1999, 868, 515-525
11. Choi, D. W.; Rothman, S. M. The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal Death Annu. Rev. Neurosci. 1990, 13, 171-182
12. Hu, N.-W.; Ondrejcak, T.; Rowan, M. J. Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances Pharmacol., Biochem. Behav. 2012, 100, 855-862
13. Coyle, J. T.; Basu, A.; Benneyworth, M.; Balu, D.; Konopaske, G. Glutamatergic synaptic disregulation in schizophrenia: therapeutic implications Handb. Exp. Pharmacol. 2012, 213, 267-295
14. Mathew, S. J.; Shah, A.; Lapidus, K.; Clark, C.; Jarun, N.; Ostermeyer, B.; Murrough, J. W. Ketamine for Treatment-Resistant Unipolar Depression CNS Drugs 2012, 26, 189-204
15. Hallett, P. J.; Spoelgen, R.; Hyman, B. T.; Standaert, D. G.; Dunah, A. W. Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking J. Neurosci. 2006, 26, 4690-4700
16. Hallett, P. J.; Standaert, D. G. Rationale for and use of NMDA receptor antagonists in Parkinson's disease Pharmacol. Ther. 2004, 102, 155-174
17. Hallett, P. J.; Dunah, A. W.; Ravenscroft, P.; Zhou, S.; Bezard, E.; Crossman, A. R.; Brotchie, J. M.; Standaert, D. G. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's disease Neuropharmacology 2005, 48, 503-516
18. Duty, S. Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson's Disease CNS Drugs 2012, 26, 1017-1032
19. Nakamura, T.; Lipton, S. A. Excitatory amino acids, S-nitrosylation, and protein misfolding in neurodegenerative disease protection by memantine and nitromemantine at NMDA-gated channels Oxid. Stress Dis. 2010, 26 (Micronutrients and Brain Health) 59-78
20. Mullasseril, P.; Hansen, K.; Vance, K.; Ogden, K.; Yuan, H.; Kurtkaya, N.; Santangelo, R.; Orr, A.; Le, P.; Vellano, K.; Liotta, D.; Traynelis, S. A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors Nature Commun. 2010, 1, 90
21. Mosley, C. A.; Acker, T. M.; Hansen, K. B.; Mullasseril, P.; Andersen, K. T.; Le, P.; Vellano, K. M.; Bräuner-Osborne, H.; Liotta, D. C.; Traynelis, S. F. Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-Selective N -Methyl- d -aspartate Receptor Antagonists J. Med. Chem. 2010, 53, 5476-5490
22. Bettini, E.; Sava, A.; Griffante, C.; Carignani, C.; Buson, A.; Capelli, A. M.; Negri, M.; Andreeta, F.; Senar-Sancho, S. A.; Guiral, L.; Cardullo, F. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors J. Pharmacol. Exp. Ther. 2010, 335, 636-644
23. Costa, B. M.; Irvine, M. W.; Fang, G.; Eaves, R. J.; Mayo-Martin, M. B.; Skifter, D. A.; Jane, D. E.; Monaghan, D. T. A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors J. Pharmacol. Exp. Ther. 2010, 335, 614-621
24. Acker, T. M.; Yuan, H.; Hansen, K. B.; Vance, K. M.; Ogden, K. K.; Jensen, H. S.; Burger, P. B.; Mullasseril, P.; Snyder, J. P.; Liotta, D. C.; Traynelis, S. F. Mechanism for Noncompetitive Inhibition by Novel GluN2C/D N -Methyl- d -aspartate Receptor Subunit-Selective Modulators Mol. Pharmacol. 2011, 80, 782-795
25. Santangelo Freel, R. M.; Ogden, K. K.; Strong, K. L.; Khatri, A.; Chepiga, K. M.; Jensen, H. S.; Traynelis, S. F.; Liotta, D. C. Synthesis and Structure-Activity Relationship of Tetrahydroisoquinoline-Based Potentiators of GluN2C and GluN2D Containing N -Methyl- d -aspartate Receptors J. Med. Chem. 2013, 56, 5351-5381
26. Acker, T. M.; Khatri, A.; Vance, K. M.; Slabber, C.; Bacsa, J.; Snyder, J. P.; Traynelis, S. F.; Liotta, D. C. Structure-Activity Relationships and Pharmacophore Model of a Noncompetitive Pyrazoline Containing Class of GluN2C/GluN2D Selective Antagonists J. Med. Chem. 2013, 56, 6434-6456
27. Hansen, B. K.; Ogden, K. K.; Traynelis, S. F. Subunit-selective allosteric inhibition of glycine binding to NMDA receptors J. Neurosci. 2012, 32, 6197-6208
28. Gauuan, P. J. F.; Trova, M. P.; Gregor-Boros, L.; Bocckino, S. B.; Crapo, J. D.; Day, B. J. Superoxide dismutase mimetics: synthesis and structure-activity relationship study of MnTBAP analogues Bioorg. Med. Chem. 2002, 10, 3013-3021
29. Kelly, M. G.; Kincaid, J.; Duncton, M.; Sahasrabudhe, K.; Janagani, S.; Upasani, R. B.; Wu, G.; Fang, Y.; Weig, Z.-L. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using same. US 2006/0194801, 2006.
30. Widmer, U. A convenient preparation of t -butyl esters Synthesis 1983, 135-136
31. Hansen, K. B.; Tajima, N.; Risgaard, R.; Perszyk, R. E.; Jørgensen, L.; Vance, K. M.; Ogden, K. K.; Clausen, R. P.; Furukawa, H.; Traynelis, S. F. Structural determinants of agonist efficacy at the glutamate binding site of N -methyl- d -aspartate receptors Mol. Pharmacol. 2013, 84, 114-127
32. Hansen, K. B.; Brauner-Osborne, H.; Egebjerg, J. Pharmacological characterization of ligands at recombinant NMDA receptor subtypes by electrophysiological recordings and intracellular calcium measurements Comb. Chem. High Throughput Screening 2008, 11, 304-315
33. Hansen, K. B.; Mullasseril, P.; Dawit, S.; Kurtkaya, N.; Yuan, H.; Vance, K.; Orr, A.; Kvist, T.; Ogden, K.; Le, P. Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N -methyl- d -aspartate receptor antagonists J. Pharmacol. Exp. Ther. 2010, 333, 650-662